Skip to main content
SpringerLink
Log in

Medikamentöse Behandlung — psychotrope Nebenwirkungen von Nichtpsychopharmaka

  • Chapter
Psychiatrie in der klinischen Medizin

Zusammenfassung

Die rasche Aufklärung psychiatrischer Syndrome unter somatischer Pharmakotherapie hat sowohl für die richtige Therapie des Patienten als auch im Hinblick auf die Vermeidung etwaiger ärztlicher Behandlungsfehler besondere Bedeutung. Das Neuauftreten psychischer Symptome in zeitlichem Zusammenhang mit einer somatischen Pharmakotherapie muss als Ausdruck einer direkten Beeinträchtigung oder Schädigung des Zentralnervensystems immer sehr ernst genommen werden und gibt Anlass zu sofortigen differenzialdiagnostischen Erwägungen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bizjak ED, Nolan PE Jr, Brody EA, Galloway JM (1999) Procainamid-induced psychosis: a case report and review of literature. Ann Pharmacother 33: 948–951

    Article  PubMed  CAS  Google Scholar 

  2. Brown ES, Suppes T (1998) Mood symptoms during corticosteroid therapy: a review. Harvard Rev Psychiatry 5: 239–246

    Article  CAS  Google Scholar 

  3. Cohen LM, Anderson G, White RF et al (1984) Enalapril and hypertension. Am J Psychiatry 141: 1012–1013

    PubMed  CAS  Google Scholar 

  4. Epperson CN, Wisner KL, Yamamoto B (1999) Gonadal steroids in the treatment of mood disorders. Psychosom Med 61: 676–697

    PubMed  CAS  Google Scholar 

  5. Gerstman BB, Jolson HM, Bauer M, Cho P, Livingston M, Platt R (1996) The incidence of depression in new users of beta-blockers and selected antihypertensives. J Clin Epidemiol 49: 809–815

    Article  PubMed  CAS  Google Scholar 

  6. Hollister LE, Trevino ES (1999) Calcium channel blockers in psychiatric disorders: a review of the literature. Can J Psychiatry 44: 658–664

    PubMed  CAS  Google Scholar 

  7. Joffe H, Cohen LS (1998) Estrogen, serotonin, and mood disturbance. Where is the therapeutic bridge? Biol Psychiatry 44: 798–811

    Article  PubMed  CAS  Google Scholar 

  8. Kasper S, Jung B (1995) Psychiatrisch relevante Nebenwirkungen der nicht-psychopharmakologischen Pharmakotherapie. Nervenarzt 66: 649–661

    PubMed  CAS  Google Scholar 

  9. Kaunitz AM (1999) Long-acting hormonal contraception: assessing impact on bone density, weight and mood. Int J Fertil Womens Med 44: 110–117

    PubMed  CAS  Google Scholar 

  10. Klimke A, Malevanyi I (2002) Psychopharmakotherapie. In: Gaebel W, MüllerSpahn F (Hrsg) Diagnostik and Therapie psychischer Störungen. Kohlhammer, Stuttgart, S 905–935

    Google Scholar 

  11. Kohn R (2001) Beta-blockers as an important cause of depression: a medical myth without evidence. Med Health R I 84 (3): 92–95

    PubMed  CAS  Google Scholar 

  12. Machleidt W, Bauer M, Lamprecht F, Rose HK, Rohde-Dachser C (1999) Psychiatrie, Psychosomatik and Psychotherapie. Thieme, Stuttgart New York

    Google Scholar 

  13. Nolan BT (1982) Acute suicidal depression associated with the use of timolol. JAMA 247: 1567

    CAS  Google Scholar 

  14. Pariante CM, Miller AH (2001) Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 49: 391–404

    Article  PubMed  CAS  Google Scholar 

  15. Porcerelli JH, Sandler BA (1998) Anabolic-androgenic steroid abuse and psychopathology. Psychiatr Clin North Am 21: 829–833

    Article  PubMed  CAS  Google Scholar 

  16. Rice C, Haltzman S, Tucek C (1988) Mania associated with procainamid (letter). Am J Psychiatry 145: 129–130

    PubMed  CAS  Google Scholar 

  17. Saadah HA (1987) A case of panic disorder precipitated by oxymetazolinewithdrawal. J Clin Psychiatry 48: 293

    PubMed  CAS  Google Scholar 

  18. Sapolsky RM (2000) Glucocorticoids and hippocampal atropy in neuropsychiatric disorders. Arch Gen Psychiatry 57: 925–935

    Article  PubMed  CAS  Google Scholar 

  19. Seidman SN, Walsh BT (1999) Testosterone and depression in aging men. Am J Geriatr Psychiatr 7: 18–33

    CAS  Google Scholar 

  20. Sternbach H, State R (1997) Antibiotics: neuropsychiatric effects and psycho-tropic interactions. Hary Rev Psychiatry 5: 214–216

    Article  CAS  Google Scholar 

  21. Uzych L (1992) Anabolic-androgenic steroids and psychiatric-related effects: a review. Can J Psychiatry 37: 23–28

    PubMed  CAS  Google Scholar 

  22. Wada K, Yamada N, Suzuki H, Lee Y, Kumoda S (2000) Recurrent cases of corticosteroid-induced mood disorder: clinical characteristics and treatment. J Clin Psychiatry 61: 261–267

    Article  PubMed  CAS  Google Scholar 

  23. Webster J, Koch HF (1996) Aspects of tolerability of centrally acting anti-hypertensive drugs. J Cardiovasc Pharmacol 27 (Suppl 3): 49–54

    Article  Google Scholar 

Download references

Authors
  1. A. Klimke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. v. Wilmsdorff
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik u. Poliklinik f. Psychiatrie u. Psychotherapie, Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Str. 11, 48129, Münster, Deutschland

    Volker Arolt

  2. Abteilung Psychiatrie und Psychotherapie, Ev. Krankenhaus Königin Elisabeth Herzberge, Herzbergstraße 79, 10362, Berlin, Deutschland

    Albert Diefenbacher

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Fachmedien Wiesbaden

About this chapter

Cite this chapter

Klimke, A., v. Wilmsdorff, M. (2004). Medikamentöse Behandlung — psychotrope Nebenwirkungen von Nichtpsychopharmaka. In: Arolt, V., Diefenbacher, A. (eds) Psychiatrie in der klinischen Medizin. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-662-12845-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-12845-9_8

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-662-12846-6

  • Online ISBN: 978-3-662-12845-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation